Buy or sell Hims stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Hims Stock
Men's wellness brand
About Hims Stock
Hims is an e-commerce wellness brand made for men with products for skin care, erectile dysfunction, and hair loss. The company works with doctors to prescribe Finasteride and Sildenafil (active ingredient in Viagra) through the app or website. With a telemedicine approach, hims allows customers to get diagnosed and treated at a lower cost and with greater convenience. Hims was incubated at San Francisco-based venture-builder, Atomic. In November 2017, the company raised $7 million in Series A funding from Thrive Capital, Forerunner Ventures, M.C. Ventures, SV Angel, Amity Supply, and Harry’s. In June 2018, hims raised $50 million in Series B funding. Institutional Venture Partners led the round which included Forerunner Ventures, Thrive Capital, Maverick Capital, and Redpoint Ventures. Hims was founded in November 2017 after CEO Andrew Dudum was called out by his sister for having dry skin and breakouts. She ordered him a bunch of expensive products to help fix the issues and Dudum quickly realized that men didn’t have the same options as women when it came to purchasing wellness products. He set out to create a company that offered simple solutions for issues many guys face. In November 2017 hims was launched and nearly four months after it was reported that the company was worth $200 million.
Investors
8VC
Anduril Industries, Sila Nanotechnologies, Cityblock Health, Blend, Aspiration, project44, Addepar, Illumio, BlueVoyant, Guardant Health
Counterpart Advisors
Scopely, TripActions, Via, Convoy, Deel, project44, Getaround, Goat Group, StockX, Turo
Forerunner Ventures
Jet, Chime, Faire, Dollar Shave Club, Warby Parker, Hims, Glossier, Zola, Away, Curated
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
Funding History
December 2013 | $11 |
---|---|
September 2017 | $753K |
September 2017 | $6.6M |
December 2017 | $24.6M |
January 2018 | $20.0M |
June 2018 | $51.4M |
February 2019 | $100M |
Management
Co-Founder & Chief Executive Officer
Andrew Dudum
Co-Founder & VP Product
Hilary Coles
Co-Founder
Jack Abraham
Chief Operating Officer
Melissa Baird
Chief Financial Officer
Spencer Lee
Press
TechCrunch - May, 20 2020
Fast Company - May, 13 2020
TechCrunch - Apr, 7 2020
TechCrunch - Feb, 5 2020
phillyvoice - Jan, 24 2019
menshealth - Jan, 24 2019
psfk - Jan, 19 2019
qz - Mar, 12 2018
Fast Company - Nov, 15 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase